Pharmacogenetic Screening for Depression Cuts Costs and Boosts Quality of Life, Study Finds https://lnkd.in/gAcv5HQf
OneDrug
Biotechnology Research
Toronto, Ontario 1,789 followers
Making Personalized Medicine Possible
About us
At OneDrug, we are advancing the implementation of precision medicine in global healthcare by developing smart point-of-care devices for the rapid identification of patients that will not respond well to drugs due to genetic defects in clinically relevant drug processing proteins. We picture a personalized healthcare system where each patient's genotype, phenotype, and physiology will be taken into account when designing their drug dosing regimen, ensuring an adequate response and minimizing unexpected adverse drug effects. Around the world, 99% of people have genetic defects that affect how they respond to medications. Abnormal drug response can lead to clinically relevant safety and efficacy issues. Adverse drug effects claim one life per minute throughout the globe, 60% of which can be avoided. As a result, adverse drug effects are the fourth biggest cause of death globally and account for $30 billion in annual healthcare spending. We are transforming the current narrative by empowering clinicians and drug developers with smart point-of-care devices to rapidly screen patients for possible clinically-relevant pharmacogenetic liabilities before making drug prescriptions and patient recruitment for clinical trials, respectively. OneDrug is making precision medicine possible across the globe!
- Website
-
https://www.onedrug.co/
External link for OneDrug
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Pharmacogenomics, precision medicine, clinical pharmacology, drug discovery, drug development, and molecular biology
Locations
-
Primary
Toronto, Ontario, CA
Employees at OneDrug
-
Chukwunonso Nwabufo, MSc, MBA
I am advancing the implementation of precision medicine in clinical care and drug development
-
Pavan Kalyan Duppati
Actively looking for SDE/Frontend/ Full Stack Positions | ASU May 2024 | Ex-Capgemini
-
Gurveer Kaur
Biomedical Research Intern @ OneDrug | Precision Medicine, Biotechnology
-
Praneeth kumar reddy kotha
Software Developer | MS Computer Software Engineer
Updates
-
Indiana University’s Precision Health Initiative Paves the Way for Sustainable Pharmacogenetics Implementation in Clinical Care https://lnkd.in/e24JarNt #pharmacogenetics #personalizedmedicine
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned
ascpt.onlinelibrary.wiley.com
-
New Research Finds Testing for DPYD Variants Alone May Not Prevent All Fluoropyrimidine Toxicities https://lnkd.in/eyuM2Ab2
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD - Genome Medicine
genomemedicine.biomedcentral.com
-
A study evaluated the risk of CYP2C19 phenoconversion, where drug metabolism changes due to drug-drug interactions. Healthy volunteers with different CYP2C19 genotypes were given omeprazole alone and with inhibitors voriconazole and fluvoxamine. Over 80% of participants experienced phenoconversion, with significant differences observed between genotypes. The findings highlight the importance of considering both genetic testing and phenotyping when predicting drug response. https://lnkd.in/exWS7qpR
Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
ascpt.onlinelibrary.wiley.com
-
📢 New study highlights the power of pharmacogenomic testing in treating depression! Patients with personalized treatment plans showed higher remission and response rates, plus fewer side effects. Personalized medicine is making a difference! 🌟 #Pharmacogenomics #DepressionTreatment #PersonalizedMedicine https://lnkd.in/eGQmhiiv
Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial
sciencedirect.com
-
📢 Attention Pharmacists and Pharmacy Managers! 📢 We're conducting a crucial survey on the Implementation of Pharmacogenetic Testing in Community Pharmacies Using Point-of-Care Diagnostic Devices. Your valuable insights will help us understand how to effectively bring this cutting-edge technology to your pharmacy. 🧬 Why Participate? Influence the development of innovative pharmacogenetic testing devices. Help improve patient care and medication management. Contribute to the future of personalized medicine in community pharmacies. 🔍 What We Need From You: Feedback on potential benefits and barriers. Your vision for integrating pharmacogenetic testing into pharmacy services. Your definition of a user-friendly testing device. 📋 Take the Survey Here: https://lnkd.in/efebJHDX Thank you for your time and insights! Together, we can revolutionize patient care and safety in community pharmacies.
Implementation of Pharmacogenetic Testing in Community Pharmacies Using Point-of-Care Diagnostic Devices
docs.google.com
-
📢 Attention Pharmacists and Pharmacy Managers! 📢 We're conducting a crucial survey on the Implementation of Pharmacogenetic Testing in Community Pharmacies Using Point-of-Care Diagnostic Devices. Your valuable insights will help us understand how to effectively bring this cutting-edge technology to your pharmacy. 🧬 Why Participate? Influence the development of innovative pharmacogenetic testing devices. Help improve patient care and medication management. Contribute to the future of personalized medicine in community pharmacies. 🔍 What We Need From You: Feedback on potential benefits and barriers. Your vision for integrating pharmacogenetic testing into pharmacy services. Your definition of a user-friendly testing device. 📋 Take the Survey Here: https://lnkd.in/efebJHDX Thank you for your time and insights! Together, we can revolutionize patient care and safety in community pharmacies.
Implementation of Pharmacogenetic Testing in Community Pharmacies Using Point-of-Care Diagnostic Devices
docs.google.com
-
Genetic insights from Tanzania: CYP2B6 and ABCB1 genes impact methadone processing in opioid-addicted patients. Tailoring treatment based on these findings could enhance safety and effectiveness. #Methadone #Genetics #PrecisionMedicine https://lnkd.in/ePwCw_xR
BPS Publications
bpspubs.onlinelibrary.wiley.com
-
🔬🧬 Discover the Future of Medicine with OneDrug! 🧬🔬 Explore how pharmacogenetics revolutionises healthcare by predicting adverse drug reactions (ADRs) and personalizing treatments. From genetic testing to advanced clinical applications, learn how OneDrug is paving the way for safer, more effective therapies. Join us on this journey towards personalized medicine! 🚀💊 #Pharmacogenetics #PersonalizedMedicine #OneDrug #HealthcareInnovation #MedicalResearch Read the article here: Frontiers | Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine (frontiersin.org)
-
🌟 Welcome to the future of healthcare with One Drug! 🌟 Personalized medicine tailored just for you. Revolutionising your treatment with innovative solutions. 💊🧬💉 #OneDrug #PersonalizedMedicine #HealthcareInnovation #FutureOfMedicine #TailoredTreatment
-
-
-
-
-
+1
-